A new study found that a DNA sequencing test for advanced prostate cancer patients can distinguish between patients with poor and favorable prognoses.

Scientists suggest that two strains of endospores located more than 4,000 kilometers away from one another originated in the ...

Pleno plans to launch its Raptor benchtop analyzer early next year, and it's poached Illumina's Vik Vaz to lead its ...

Scientists identified early genetic mutations in healthy women’s breast cells that may lead to breast cancer, particularly in ...

Published in Nature Communications, a new study led by the University of Minnesota Medical School and Duke University found ...

At ASH's annual meeting, a study showed the potential for this method to inform the next treatment after patients relapse on BCMA- or GPRC5D-targeted therapy.

Pancreatic cancer is the third leading cause of cancer death in the U.S. That's due in part to the limited testing available for early detection. Now, researchers at Johns Hopkins say they've made a ...

Johns Hopkins researchers have developed a powerful new AI tool called "Splam" that can identify where splicing occurs in ...

DNA stores the instructions for life and, along with enzymes and other molecules, computes everything from hair color to risk ...

Michael Niederweis, Ph.D., and Cynthia Owsley, Ph.D., who collectively hold 23 patents, have been recognized for approaches ...

Illumina Vice President of Bioinformatics James Han has been in the industry for decades—so he’s witnessed every stride the ...

Researchers have developed a new, fast, and rewritable method for DNA computing that promises smaller, more powerful ...